is semaglutide a controlled substance The push for Medicare to cover weight-loss drugs: An explainer FDA Ban on Compounded GLP-1

It is worth noting that for elderly people who are not obese or on the verge of sarcopenia, excessive weight loss may accelerate the progression of sarcopenia and increase the risk of falls and poor prognosis

5 Weight loss plays a significant role in improving symptoms among HFpEF patients with obesity-related HF

How the Landscape Changed in 2025 and 2026 For roughly two years, compounded GLP-1s were widely available because the approved products were in shortage

Neither platform currently integrates genetic peptide pathway testing as a standard offering, though some Brello prescribers may offer adjunct assessments

Translating the integrated framework this article has described into responsible clinical practice requires the same precision that the science demands